121 related articles for article (PubMed ID: 27995116)
1. Studying the effect of type 2 diabetes mellitus on prostate-related parameters: A prospective single institutional study.
Elabbady A; Hashad MM; Kotb AF; Ghanem AE
Prostate Int; 2016 Dec; 4(4):156-159. PubMed ID: 27995116
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
[TBL] [Abstract][Full Text] [Related]
3. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
[TBL] [Abstract][Full Text] [Related]
4. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
6. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
7. Influence of opioid consumption on serum prostate-specific antigen levels in men without clinical evidence of prostate cancer.
Hosseini SY; Amini E; Safarinejad MR; Soleimani M; Lashay A; Farokhpey AH
Urology; 2012 Jul; 80(1):169-73. PubMed ID: 22748872
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC
J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk.
Morote J; Planas J; Ramirez C; Gómez E; Raventós CX; Placer J; Catalán R; de Torres IM
BJU Int; 2010 Feb; 105(4):481-4. PubMed ID: 19681902
[TBL] [Abstract][Full Text] [Related]
10. Serum level of prostate-specific antigen in diabetic patients in Basrah, Iraq.
Al-Asadi JN; Al-Naama LM; Abdul-Kareem MM; Mashkoor FC
Niger Postgrad Med J; 2017; 24(4):240-244. PubMed ID: 29355164
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
Chung BH; Hong SJ; Cho JS; Seong DH
BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
[TBL] [Abstract][Full Text] [Related]
12. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
13. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
[TBL] [Abstract][Full Text] [Related]
15. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.
Ulleryd P; Zackrisson B; Aus G; Bergdahl S; Hugosson J; Sandberg T
BJU Int; 1999 Sep; 84(4):470-4. PubMed ID: 10468764
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
19. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
[TBL] [Abstract][Full Text] [Related]
20. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
